Study of VYD2311 for the Treatment of Adults With Long-COVID or Post-Vaccination Syndrome
Study sponsor: Invivyd, Inc. · IVVD
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2027-06Estimated
Enrollment · participants130Estimated
Source updated2026-10-27Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.